TRACON Pharmaceuticals, Inc. (TCON)
OTHER OTC:TCON
Holding TCON?
Track your performance easily

TRACON Pharmaceuticals (TCON) Financial Statements

703 Followers

TRACON Pharmaceuticals Financial Overview

TRACON Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $3.789; its P/E ratio is 0.05; TRACON Pharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 55.00K$ 100.00K$ 3.04M-$ 9.00M
Gross Profit$ 55.00K$ 100.00K$ 3.04M-$ 9.00M
EBIT$ -2.84M$ -3.17M$ 464.00K$ 6.76M$ 2.46M
EBITDA$ -2.83M$ -3.16M$ 471.00K$ 7.44M$ 8.01M
Net Income Common Stockholders$ -2.84M$ -3.17M$ 439.00K$ 6.76M$ -6.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.27M$ 7.89M$ 8.56M$ 7.76M$ 1.74M
Total Assets$ 7.40M$ 9.36M$ 10.11M$ 9.41M$ 12.15M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.27M$ -7.89M$ -8.56M$ -7.76M$ -1.74M
Total Liabilities$ 10.49M$ 11.12M$ 10.91M$ 12.50M$ 27.93M
Stockholders Equity$ -3.09M$ -1.76M$ -809.00K$ -3.08M$ -15.74M
Cash Flow-
Free Cash Flow$ -2.77M$ -2.54M$ -522.00K$ 15.05M$ -5.85M
Operating Cash Flow$ -2.77M$ -2.54M$ -522.00K$ 15.05M$ -5.85M
Investing Cash Flow-----
Financing Cash Flow$ 1.15M$ 1.87M$ 1.32M$ -9.09M$ 1.05M
Currency in USD

TRACON Pharmaceuticals Earnings and Revenue History

TRACON Pharmaceuticals Debt to Assets

TRACON Pharmaceuticals Cash Flow

TRACON Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis